Certified by Founder Lodge
Cathay Health
France - Paris
INVESTOR
1 Disclosed Funding Rounds $31,300,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cathay Health, affiliated to Cathay Capital, is a global fund investing at the convergence of healthcare, life sciences and technology.
We back venture to growth-stage companies across Eu
| Company | Date | Round | Raised |
|---|---|---|---|
 Moon Surgical |
June, 30 ,2022 | Series A | $31,300,000 |
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 TISSIUM |
May, 23 ,2023 | Series D | $50,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
